BetaShares Geared Austra... Stock Quote GEAR - Stock Price, News, Charts, Message Board, Trades

Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Home
Investing
ETFs
Australia
ASX
BetaShares Geared Australian Equity Fund (GEAR) Quote

BetaShares Geared Australian Equity Fund (GEAR)

28.84

0.02

(0.07%)

Closed March 22 1:00AM

Delayed by 20 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

28.84

Bid

28.81

Ask

29.20

Volume

194,180

28.65 Day's Range 29.20

0.00 52 Week Range 0.00

Market Cap

Previous Close

28.82

Open

28.72

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

15,787,000

Dividend Yield

-

PE Ratio

5.25

Earnings Per Share (EPS)

5.49

Revenue

120.72M

Net Profit

86.72M

Sector

Finance Services

Industry

Finance Services

Website

betashares.com.au

Headquarters

Sydney, New South Wales, Aus

Founded

-

BetaShares Geared Australian Equity Fund is listed in the Finance Services sector of the Australian Stock Exchange with ticker GEAR. The last closing price for BetaShares Geared Austra... was AUD28.82. Over the last year, BetaShares Geared Austra... shares have traded in a share price range of AUD 0.00 to AUD 0.00.

BetaShares Geared Austra... currently has 15,787,000 shares outstanding. The market capitalization of BetaShares Geared Austra... is AUD454.98 million. BetaShares Geared Austra... has a price to earnings ratio (PE ratio) of 5.25.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SGLYSingularity Future Technology Ltd	$ 1.6799 (143.43%)	30.76M
WINVWinVest Acquisition Corporation	$ 25.00 (107.30%)	463
VVPRVivoPower International PLC	$ 1.2899 (52.13%)	65.08M
RNAZTransCode Therapeutics Inc	$ 1.12 (45.45%)	216.22M
GLTOGalecto Inc	$ 6.00 (44.93%)	10.71M
YHCLQR House Inc	$ 0.40 (-82.38%)	38.32M
KZIAKazia Therapeutics Ltd	$ 0.9759 (-80.02%)	55.66k
DMNDamon Inc	$ 0.0373 (-70.02%)	304.17M
TCBPTC BioPharm Holdings PLC	$ 0.5046 (-67.23%)	5.9M
SOWGSow Good Inc	$ 1.53 (-44.36%)	698.02k
DMNDamon Inc	$ 0.0373 (-70.02%)	304.17M
NVDANVIDIA Corporation	$ 117.70 (-0.70%)	264.42M
RNAZTransCode Therapeutics Inc	$ 1.12 (45.45%)	216.22M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 9.03 (10.66%)	175.77M
HOLOMicroCloud Hologram Inc	$ 1.00 (32.36%)	141.98M

Rendering Error

Krungster10

Krungster10 5 minutes ago

Sounds like you have some type of hero complex to think you are out here saving grown folks that are making their own financial decisions. Who are you to tell anyone what not to buy with their own money?

Truthsocial

Truthsocial 5 minutes ago

Exactly absolutely

Bigfootbud

Bigfootbud 7 minutes ago

Ok, cool! Looks like trumpcancer.com has been registered since 7/25/2005!! Long time!

WHOIS search results
Domain Information
NameTRUMPCANCER.COMRegistry Domain ID189029673_DOMAIN_COM-VRSN
Registered On 2005-07-25 T 23:53:48Z
Expires On 2025-07-25 T 23:53

fung_derf

fung_derf 7 minutes ago

Keep howling at the moon Fung. Nobody is selling $DBMM.

Or buying it seems.
Therefore, no one need post here and yet here you are!

Ayock

Ayock 7 minutes ago

Your cult doesn't seem to care...

https://scontent-lax3-1.xx.fbcdn.net/v/t39.30808-6/485739739_1125751009656472_2638257754763246620_n.jpg?_nc_cat=110&ccb=1-7&_nc_sid=833d8c&_nc_ohc=HIFOXUeljRQQ7kNvgGrTA7E&_nc_oc=Adn0mhz5WMG-x509_zDcd6MVHfJ6fcxqBTy9s64GUlNo8agAot8eeruhg_067v4UsOBzoWnSo

Steady_T

Steady_T 8 minutes ago

Once approval comes, your threatened lawsuit will be years before it could possibly have results, assuming it is not dismissed early on.

Not something I'm worried about at the present time.

Bubae

Bubae 8 minutes ago

D your really think anyone is buying that line. You will need to do better to flip your position. $11 a shares. Meanwhile the weekly conversions continue next week with a basis price of $0.0003. You think maybe they should be holding for $11.00. The price of ECVO at $11.00 is a very thinly and very

ddls

ddls 9 minutes ago

Yes, thanks for all the BIEL-bullshit throughout the-years. 🤠

One more week and my March share volume comes out.

I can tell you as of current numbers they're not looking too good.

The pumpaholoic's better come up with something good this week or M

WALLnut

WALLnut 9 minutes ago

You wouldn’t know “keeping it real” if it smacked you in the face. Your entire argument is built on a deliberate misrepresentation of what makes a medical technology valuable.

Yes, RadioGel’s original patents are old—but you conveniently ignore the fact that Vivos has developed and se

vuletini

vuletini 12 minutes ago

hotmeat

hotmeat 12 minutes ago

Not even close to being the same liar......you've been informed of this FACT repeatedly and yet you continue to maliciously promote this false narrative.

Good thing for us Vivos shareholders no one believes your incessant mindless drivel. lol

fung_derf

fung_derf 13 minutes ago

Why do Professors teach when they can do instead? Why do you hate educators so?
You talk of kids picking noses and people have no reason for educating.
Why are you so opposed to objectivity and balance on a board?
Did you get picked on a lot in school for being slow?

Eagle1

Eagle1 14 minutes ago

Hope Everyone has a great and safe weekend!

jondoeuk

jondoeuk 16 minutes ago

It is too risky for IPSC, so I will watch from the sidelines. As for FATE, I will wait to see the data (FT819) that should be presented at the EULAR Congress, in June.

sortagreen

sortagreen 17 minutes ago

These are some rookie numbers here...

Three killed and 15 injured in New Mexico mass shooting
3 hours ago
Kayla Epstein

Three people were killed and 15 others injured in a mass shooting between two rival groups at an unsanctioned car show on Friday in the

Paulie Cashews

Paulie Cashews 17 minutes ago

So, what's your problem with the ad? Seems like a good deal - just answer a few questions, and they'll send you a free Gift Card.

I'm sure they'll keep your Social Security number and credit card info safe and secure!

Or, you could pay up and buy an IHUB subscription, a

ksquared

ksquared 17 minutes ago

California Dems nervous about Republicans speaking out — and possibly losing control
By Susan Shelley Published March 22, 2025, 11:00 a.m. ET Other Assembly Republicans were removed from their committees after such “offenses” as opposing the bullet train, warning that the state’s mishandl

manibiotech

manibiotech 17 minutes ago

Except they don't have data on any of those cancers listed in the table to apply for an approval . Before you point to any early stage or phase 1 trials , I think my statement is clear about the data they can actually use to apply for an approval.

johnydollar

johnydollar 19 minutes ago

Can one say it loud, myopic 👀........

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹

fung_derf

fung_derf 19 minutes ago

Now, you can't state you're done posting here then start again.
For the record, I have never shorted a stock in my 30 years of investing. Even when I can see it would be the smart thing to do.
I also, don't take positions in penny stocks and shorting one seems silly considering all the

SC8

SC8 20 minutes ago

How is Radiogel "groundbreaking" when it was invented over two decades ago, all the original patents have expired and RDGL has at least one competitor we know of that beat them to human trials back in 2022?

Just keeping it real.

DTGoody

DTGoody 20 minutes ago

AFFU Management if you are reading this message board put out some news and get your stock price back up to a respectable level! I am relativity new here, but you have longs who have toughed out the rough times with your company prior to Covid who deserve a lot better. For their sake do not screw ov

WALLnut

WALLnut 21 minutes ago

The Future of Cancer Treatment: Why RadioGel® Will Be a Game-Changer After IDE Approval and What’s Next for IsoPet®

RadioGel® is on the verge of redefining cancer treatment, especially for localized tumors that are difficult to remove surgically or treat with traditional radiation the

BetaShares Geared Austra...

Delayed Upgrade Clock